BlueCross BlueShield of Tennessee Medical Policy Manual

Intraoral Devices for the Treatment of Headaches

DESCRIPTION

Intraoral devices are proposed as a treatment of headache (e.g., migraine, tension-type). An example of an intraoral device developed for the prophylactic prevention of headache is the Nociceptive Trigeminal Inhibition Tension Suppression System or NTI-tss®. This device fits over the two maxillary central incisors and has a dome-shaped protrusion which extends lingually. The dome is customized by the provider to act as single point contact at the incisal embrasure of the two mandibular central incisors, thereby preventing posterior or canine tooth contact.

POLICY

IMPORTANT REMINDERS

ADDITIONAL INFORMATION

Well-designed studies published in peer-reviewed journals are lacking regarding the use of any intraoral device for the treatment of headaches.

SOURCES

Almasan, O., Hedesiu, M., Leucuta, D-C., Buduru, S., & Dinu, C. (2022). Oral splints in the management of nociceptive pain and migraines: A scoping review. Experimental and Therapeutic Medicine, 25 (1), 28. (Level 3 evidence)

American Headache Society and American Academy of Neurology. (2012). The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Retrieved July 22, 2020 from https://americanheadachesociety.org/resources/guidelines/guidelines-position-statements-evidence-assessments-and-consensus-opinions/.  

Bruno, M.A.D., & Krymchantowski, A.V. (2018). Amitriptyline and intraoral devices for migraine prevention: a randomized comparative trial. Arquivos de neuro-psiquiatria, 76 (4), 213-218. (Level 4 evidence)

Franco, L., Rompre, P., de Grandmont, P., Abe, S., & Lavigne, G. (2011). A mandibular advancement appliance reduces pain and rhythmic masticatory muscle activity in patients with morning headache. Journal of Orofacial Pain, 25 (3), 240-249. (Level 3 evidence)

Stapelmann, H., & Turp, J. C. (2008). The NTI-tss® device for the therapy of bruxism, temporomandibular disorders, and headache - where do we stand? A qualitative systematic review of the literature. BMC Oral Health, 8 (22). (Level 2 evidence)

U. S. Food and Drug Administration. (2001, June). Center for Devices and Radiological Health. 510(k) Premarket Notification Database. K010876 (NTI-tts®). Retrieved February 6, 2012 from http://www.accessdata.fda.gov.  

ORIGINAL EFFECTIVE DATE:  9/1/2002

MOST RECENT REVIEW DATE:  12/14/2023

ID_BT

Policies included in the Medical Policy Manual are not intended to certify coverage availability. They are medical determinations about a particular technology, service, drug, etc. While a policy or technology may be medically necessary, it could be excluded in a member's benefit plan. Please check with the appropriate claims department to determine if the service in question is a covered service under a particular benefit plan. Use of the Medical Policy Manual is not intended to replace independent medical judgment for treatment of individuals. The content on this Web site is not intended to be a substitute for professional medical advice in any way. Always seek the advice of your physician or other qualified health care provider if you have questions regarding a medical condition or treatment.

This document has been classified as public information.